Hedge Fund - Touradji Capital Management

Paul Touradji Bio, Returns, AUM, Net Worth

Tiger cub Paul Touradji founded Touradji Capital Management in January 2005 after commodities fund Catequil Asset Management, his previous venture, folded in the wake of a feud with his partner, Robert Ellis. Touradji Capital Management operates out of the Tiger offices in New York. Paul Touradji handles the trading as well as the day-to-day management of his Touradji Capital Management.

Tiger cub Paul Touradji founded Touradji Capital Management in January 2005 after commodities fund Catequil Asset Management, his previous venture, folded in the wake of a feud with his partner, Robert Ellis. Touradji Capital Management operates out of the Tiger offices in New York. Paul Touradji handles the trading as well as the day-to-day management of his Touradji Capital Management.

Since starting his new fund, Paul Touradji enjoyed a fair degree of success, logging six consecutive years of growth, that is until 2011. Facing his flagship fund's first losing year, Paul Touradji opted to try a new strategy, dropping responsibility for the fund's daily operations and lending his attentions entirely to managing the firm's trades. "Simply put, the daily operation of the firm must go from being a major time and energy drain on me to an integral support function for our entire team, allowing us to concentrate our full attention on investment performance," said Paul Touradji.

As part of the shake up, two executives left and the firm and two new ones came on board, including Peter Borish, the former head of research at Tudor Investment Corp, who was hired on as Touradji Capital's CEO. Paul Touradji, understanding the riskiness of his move, offered investors the chance to redeem their investments.

Show More
Paul Touradji
Fund Profile
Filing Period:
Fund Name: Touradji Capital Management
Manager Paul Touradji
Portfolio Value $0
Change This QTR 0.00%
Fund Holdings Sector Distribution
Filing Period:
No. Security Ticker Shares Value Activity % Port History
1. BIOA 0 $0 0%
2. ABX 0 $0 0%
News, Interviews and Investor Letters